Healthcare / Health Information ServicesCanadian Sec
$0.07
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-466136.00 · quality 36.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
19/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-103.4%
↓Gross Margin
90.6%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-84.1%
FCF CAGR
—
FCF margin
-27195.8%
FCF / Net income
0.84x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1714.0 · net income $-554476.0 · FCF $-466136.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1714.00 | $1714.00 | $96342.00 | $171215.00 | $424928.00 |
| Net Income | $-554476.00 | $-554476.00 | $-433075.00 | $-1.2M | $-1.2M |
| EBITDA | $-635995.00 | $-635995.00 | $-429235.00 | $-1.2M | $-1.2M |
| EPS | -0.01 | -0.01 | — | -0.03 | -0.03 |
| Gross Margin | 90.6% | 90.6% | 69.9% | 26.2% | 54.1% |
| Operating Margin | -37220.5% | -37220.5% | -472.7% | -728.7% | -276.6% |
| Net Margin | -32349.8% | -32349.8% | -449.5% | -719.6% | -276.2% |
| Balance Sheet | |||||
| Current Ratio | 22.24 | 22.24 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-466136.00 | $-466136.00 | $-221638.00 | $-1.0M | $-1.1M |
| Returns | |||||
| ROE | -103.4% | -103.4% | -51.6% | -215.1% | -72.0% |
| Valuation | |||||
| P/B | 5.46 | 5.46 | 6.48 | 13.46 | 5.84 |
| Growth & Yield | |||||
| Revenue Growth | -98.2% | -98.2% | -43.7% | -59.7% | — |
| EPS Growth | — | — | — | 0.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+366.7%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → -0.01
Residual
+366.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.